biotech · Pulmonary Disease, Chronic Obstructive · Symptomatic Neurogenic Orthostatic Hypertension · TBPH
Theravance Biopharma Ireland
Theravance Biopharma Ireland Umited
Theravance Biopharma Ireland clinical programs — 19 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 901 Gateway Blvd., South San Francisco, CA 94080, US
- Founded
- 2014
- Employees
- 177
- Programs
- 57
- Drugs
- 18
- Patents
- 635
Theravance Biopharma Ireland projects
19 ClinicalTrials.gov programs sponsored by Theravance Biopharma Ireland.
Theravance Biopharma Ireland has 19 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
400 microgrammes GSK961081
Theravance Biopharma Ireland Umited
Pulmonary Disease, Chronic Obstructive
1 trial -
Placebo
Theravance Biopharma Ireland Umited
Chronic Obstructive Pulmonary Disease, COPD
1 trial -
Placebo
Theravance Biopharma Ireland Umited
Crohn's Disease
1 trial -
Revefenacin Inhalation Solution [Yupelri]
Theravance Biopharma Ireland Umited
COPD
1 trial -
TD-0903
Theravance Biopharma Ireland Umited
Acute Lung Injury (ALI) Associated With COVID-19
2 trials -
TD-1211
Theravance Biopharma Ireland Umited
Opioid Induced Constipation
2 trials -
TD-1211
Theravance Biopharma Ireland Umited
Healthy
2 trials -
TD-1211
Theravance Biopharma Ireland Umited
Opioid-induced Constipation (OIC)
1 trial -
TD-1792
Theravance Biopharma Ireland Umited
Staphylococcal Skin Infection
1 trial -
TD-4208
Theravance Biopharma Ireland Umited
Chronic Obstructive Pulmonary Disease
1 trial -
TD-4208
Theravance Biopharma Ireland Umited
COPD
2 trials -
TD-5108
Theravance Biopharma Ireland Umited
Chronic Constipation
1 trial -
TD-8236
Theravance Biopharma Ireland Umited
Asthma
2 trials -
TD-9855
Theravance Biopharma Ireland Umited
Neurogenic Orthostatic Hypotension
1 trial -
TD-9855
Theravance Biopharma Ireland Umited
Attention-Deficit/Hyperactivity Disorder
1 trial -
TD-9855 Group 1
Theravance Biopharma Ireland Umited
Fibromyalgia
1 trial -
Telavancin
Theravance Biopharma Ireland Umited
Infection
1 trial -
Velusetrag
Theravance Biopharma Ireland Umited
Gastroparesis
1 trial -
velusetrag dose 1
Theravance Biopharma Ireland Umited
Gastroparesis
1 trial
Frequently asked questions
How many clinical projects does Theravance Biopharma Ireland have?
19 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.